薬物動態
Print ISSN : 0916-1139
シミュレーションによるリボソーム封入ドキソルビシンの抗腫瘍効果の最適化とその実験的検証
土橋 麻理飯田 慎也原島 秀吉際田 弘志
著者情報
ジャーナル フリー

1997 年 12 巻 supplement 号 p. 90-91

詳細
抄録
To estimate quantitative information of antitumor effect, simulations were performed by the physiological model linked with a cell kill kinetic model. Antitumor effect of liposomal DOX was increased with the increase of blood circulating time. There was the optimum rate of drug release (krel) from long circulating liposomes. To examine this model, we prepared liposomes with different krel, which can be made by changing lipid composition such as HEPC, EPC and CHO. Antitumor effect of liposomal DOX with different krel was evaluated by survival experiments. Liposomes with the lowest krel showed the highest antitumor effect. This result was different from our predicitori based on the computer simulations, which regured some corrections of our model.
著者関連情報
© 日本薬物動態学会
前の記事 次の記事
feedback
Top